Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Non-cash Items (2019)

Madrigal Pharmaceuticals (MDGL) has disclosed Non-cash Items for 5 consecutive years, with $673303.0 as the latest value for Q1 2019.

  • Quarterly Non-cash Items changed N/A to $673303.0 in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $673303.0 through Mar 2019, changed N/A year-over-year, with the annual reading at $70082.0 for FY2014, 98.2% down from the prior year.
  • Non-cash Items for Q1 2019 was $673303.0 at Madrigal Pharmaceuticals, down from $5.5 million in the prior quarter.
  • The five-year high for Non-cash Items was $5.6 million in Q2 2015, with the low at $673303.0 in Q1 2019.